A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder

@inproceedings{Goddard2015ACT,
  title={A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder},
  author={Andrew W. Goddard and Waqar Mahmud and Carla E Medlock and Yong-Wook Shin and Anantha S Shekhar},
  booktitle={Annals of general psychiatry},
  year={2015}
}
BACKGROUND Open-label quetiapine coadministration with SSRI therapy, in a diagnostically mixed sample of comorbid anxiety patients, offered additional anxiolytic benefit. Therefore, we designed the following controlled trial to confirm these findings in a comorbid, SSRI-resistant, panic disorder (PD) patient sample. METHODS This was a single-site, double-blind, placebo-controlled (PLAC), randomized, parallel group (2 groups), 8-week, quetiapine extended release (XR) coadministration trial… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 27 references

A randomized, double‐blind, placebo‐controlled study of ziprasidone monotherapy in bipolar disorder with Co‐occurring lifetime panic or generalized anxiety disorder

  • T Suppes
  • J Clin Psychiatry
  • 2014

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active‐controlled study

  • C Merideth
  • Int Clin Psychopharmacol
  • 2012

A randomized, double‐blind study of once‐daily extended release quetiapine fumarate (Quetiapine XR) monotherapy in patients with generalized anxiety disorder

  • A Khan
  • J Clin Psychopharmacol
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…